Nisa Investment Advisors LLC Has $8.85 Million Stock Position in Humana Inc. (NYSE:HUM)

Nisa Investment Advisors LLC increased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 13.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,342 shares of the insurance provider's stock after acquiring an additional 3,929 shares during the period. Nisa Investment Advisors LLC's holdings in Humana were worth $8,852,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. denkapparat Operations GmbH acquired a new stake in shares of Humana during the fourth quarter worth $323,000. Allstate Corp acquired a new stake in shares of Humana during the fourth quarter worth $905,000. Deutsche Bank AG raised its holdings in shares of Humana by 18.2% during the fourth quarter. Deutsche Bank AG now owns 631,371 shares of the insurance provider's stock worth $160,185,000 after acquiring an additional 97,071 shares during the period. Janney Montgomery Scott LLC acquired a new stake in shares of Humana during the first quarter worth $1,309,000. Finally, Fred Alger Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $451,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on HUM. Guggenheim began coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Wall Street Zen upgraded shares of Humana from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Oppenheimer lifted their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Finally, Truist Financial set a $280.00 price target on shares of Humana and gave the company a "hold" rating in a research note on Tuesday, June 17th. Sixteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus target price of $280.76.

Humana Stock Performance

Shares of Humana stock traded down $1.80 during trading on Friday, hitting $230.38. 1,077,538 shares of the stock were exchanged, compared to its average volume of 1,814,856. The stock has a market capitalization of $27.80 billion, a price-to-earnings ratio of 16.29, a price-to-earnings-growth ratio of 1.75 and a beta of 0.44. The company has a fifty day moving average price of $238.33 and a 200-day moving average price of $258.48. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. Humana's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the business earned $7.23 EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.54%. Humana's dividend payout ratio (DPR) is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.